Plasma Prekallikrein and Endotoxemia in Liver Cirrhosis

Summary

In liver disease low prekallikrein levels may be found which has been suggested to be due to diminished synthesis. However, it may also be due to endotoxemia accompanying liver disease. To study the last possibility prekallikrein, endotoxins and Normotest were determined in 18 cirrhosis patients. The relation between the prekallikrein concentration (after 15 min activation) and the Normotest was significant (r = +0.72, P <0.001). Endotoxemia was only found in the more severe forms of liver disease (Normotest below 60%). During endotoxemia the prekallikrein levels were significantly lower than when no endotoxins were present in the blood of the same patients. The Normotest did not differ significantly in these patients in relation to the presence or absence of endotoxins. The activation of prekallikrein was slower in the more severe forms of liver disease. This might be due to reduced levels of factor XII and high molecular weight kininogen.

Keywords

Prekallikrein - Prekallikrein activation - Normotest - Endotoxin - Cirrhosis - Liver disease

• References

• 1 Chan JY C, Habal FM, Burrowes CE, Movat HZ. Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein. Thromb Res 1976; 09: 423-433
• 2 Clemente C, Bosch J, Rodés J, Arroyo V, Mas A, Maragall S. Functional renal failure and haemorrhagic gastritis associated with endotoxemia in cirrhosis. Gut 1977; 18: 556-560
• 3 Cochrane CG, Griffin JH. Molecular assembly in the contact phase of the Hageman factor system. Am J Med 1979; 67: 657-664
• 4 Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenetic role of endotoxin in Reye’s syndrome. Lancet 1975; 01: 1272-1274
• 5 Elin RJ, Wolff SM. Biology of endotoxin. Annu Rev Med 1976; 27: 127-141
• 6 Friberger P, Eriksson E, Gustavsson S, Cleason G. Determination of prekallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kallikrein. Adv Exp Med Biol 1979; 120A: 67-82
• 7 Fujii M, Yasunaga K, Uchino H. Correlation analysis of relationships between vitamin-K-dependent clotting factors and effective hepatic blood flow, albumin and other liver function tests. Haemostasis 1980; 09: 09-14
• 8 Kaplan AP, Austen KF. A pre-albumin activation of prekallikrein. J Immunol L970;105: 802-81L and J Exp Med 1971; 133: 696-712
• 9 Kluft C. Blood fibrinolysis. Proactivators and activators in human plasma. Thesis; Leiden: 1978
• 10 Mandle RJ, Colman RW, Kaplan AP. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci USA 1976; 73: 4179-4183
• 11 Meier HL, Pierce JV, Colman RW, Kaplan AP. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest 1977; 60: 18-31
• 12 Morrison DC, Cochrane CG. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med 1974; 140: 797-811
• 13 Poller L. Coagulation abnormalities in liver disease. In: Poller L. ed. Recent advances in blood coagulation. Edinburgh: Churchill Livingstone; 1977. 267-292
• 14 Robinson JA, Klodnycky ML, Loeb HS, Racic MR, Gunnar RM. Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man. Am J Med 1975; 59: 61-67
• 15 Saito H. Determination of Hageman factor (HG, factor XII) and plasma prekallikrein (Fletcher factor) by radioimmunoassays. Adv Exp Med Biol 1979; 120A: 165-172
• 16 Saito H, Poon MC, Vide W, Goldsmith GH, Menitove JE. Human plasma prekallikrein (Fletcher factor) clotting activity and antigen in health and disease. J Lab Clin Med 1978; 92: 84-95
• 17 Stormorken H, Baklund A, Gallimore M, Ritland S. Chromogenic substrate assay of plasma prekallikrein. Haemostasis 1978; 07: 69-75
• 18 Van Vliet ACM, Maas HC M, Wilson JH P. The effect of portasystemic shunting and RES function on endotoxemia in human liver disease. In: Liehr H, Grün M. eds. The reticuloendothelial system and the pathogenesis of liver. Amsterdam: Elsevier/ North-Holland, Biomedical; 1980. 159-164
• 19 Wong PY. The kallikrein-kinin and related vasoactive systems in cirrhosis of the liver. In: Epstein M. ed. The kidney in liver disease. New York: Elsevier; 1978. 299-310